CVS Health Corp CVS shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guidance.
CVS Health reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $2.15. The company also reported quarterly sales of $76.83 billion which beat the analyst consensus estimate of $75.39 billion by 2%.
CVS Health also raised FY22 adjusted EPS guidance from as low as $8.10 or as high as $8.30 to as low as $8.20 or as high as $8.40, versus the analyst consensus estimate of $8.27.
See Also: Why Lyft Shares Are Slamming The Brakes Today
CVS Health operates nearly 9,900 retail pharmacy locations.
According to data from Benzinga Pro, CVS Health has a 52-week high of $111.25 and a 52-week low of $76.70.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
